German Christopher Paul bought RYTM
July 9, 2025 · Form 4 insider transaction
German Christopher Paul bought 2,000 shares of Rhythm Pharmaceuticals, Inc. at $17.97 per share, a transaction worth $35.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$17.97
Total value
$35.9K
InsiderGerman Christopher Paul
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2025
Filing dateJuly 11, 2025
Shares owned after3,889
OwnershipDirect
10b5-1 planNo
AmendedNo